The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...
- The MosaiQ CENP-B microarray immunoassay designed for the detection of Auto-antibodies to Centromere Protein B - The MosaiQ AiPlex CTD microarray immunoassay designed as an aid in diagnosis of ...
PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry Analyst at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback